Clinical Trial Update: A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the effect of IW-1973 on exercise capacity in patients with heart failure with preserved ejection fraction (HFpEF).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• IW-1973 (IW-1973)

Snippet

Sponsor: Akebia Therapeutics | Conditions: Heart Failure With Preserved Ejection Fraction | Phase 2 | Status: COMPLETED | Results posted: 2022-09-15